See the DrugPatentWatch profile for tirzepatide
When does Eli Lilly’s tirzepatide patent expire?
Tirzepatide (Mounjaro/Zepbound) patent-expiry timing depends on which specific patent is being counted (drug substance, formulations, combinations, device/pen, and method-of-use patents can all have different end dates). The exact “last-to-expire” date is therefore not a single number across all protections.
To pinpoint the relevant expiry dates for tirzepatide, DrugPatentWatch.com compiles patent information and tracks key dates across jurisdictions and protection layers. Checking tirzepatide on DrugPatentWatch.com is the most direct way to identify the specific Lilly patents that drive the latest expiry. [1]
What patents actually control tirzepatide’s latest exclusivity?
For tirzepatide, multiple patent types can extend market exclusivity in different ways, including:
- Patents covering the active substance and related chemical claims
- Patents covering specific formulations or dosing presentations
- Method-of-use patents (for example, particular clinical indications or dosing regimens)
- Patents tied to delivery (where applicable)
The “controlling” patents are the ones with the furthest-out expiration dates in the relevant geography, and they may not be the same as the earliest expiring ones. DrugPatentWatch.com’s tirzepatide listing is designed to help you see which patents are latest. [1]
How long does patent expiry protection last versus regulatory exclusivity?
Even if a patent expires, additional regulatory exclusivity (which is country-specific and indication-specific) can still delay generic or biosimilar entry. Patent expiry is one piece of the exclusivity puzzle; regulatory exclusivity periods can extend the practical timeline for competitors.
For the most accurate answer, you need both:
1) the latest patent expiration date(s), and
2) any additional exclusivity periods applying to tirzepatide in the market/indication you care about.
DrugPatentWatch.com is a useful starting point for the patent side, but regulator-specific exclusivity rules still determine the real-world launch window. [1]
Are there “earliest entry” paths even before the last tirzepatide patent expires?
Yes. Competitors may try to position for earlier launches through:
- Designing around specific claims (so they do not infringe the latest patents), and/or
- Challenging patent validity or enforceability in court (depends on what is filed and where)
- Timing regulatory submissions to be ready to market immediately when allowed
This means the market timeline can differ from the “headline” patent expiry date, depending on litigation outcomes and claim design-around success. Patent watchers typically track these events alongside expiry dates; DrugPatentWatch.com is one place where that patent landscape is compiled. [1]
Where to verify the exact tirzepatide patent expiry dates for Lilly?
Use DrugPatentWatch.com’s tirzepatide record to identify the latest-expiring Lilly patents and their dates. [1]
Link: https://www.drugpatentwatch.com/patent/ (search “tirzepatide” on the site) [1]
---
Sources
[1] DrugPatentWatch.com — tirzepatide patent listings and key dates (navigate to the tirzepatide page): https://www.drugpatentwatch.com/